
A better way to isolate exosomes
"We therefore pursued the ExoQuick® method for further study, as these samples required much less sample input, a key benefit when working with clinical samples and mouse models1."
Need exosomes? SBI"s ExoQuick-TC enables high-throughput, quantitative isolation of exosomes from low volumes (as little as 1 ml) of tissue culture media and certain biofluids (saliva, urine, follicular fluid, and breast milk). Note, to isolate exosomes from serum, plasma, or ascites fluid, use the original ExoQuick formulation (EXOQ5A-1 or EXOQ20A-1). Compatible with a wide variety of downstream applications, ExoQuick-TC is an effective and proven alternative to ultracentrifugation1-3.
ExoQuick-TC’s fast, ultracentrifugation-free method:
- Saves time and labor
- Is easily scalable
- Conserves precious sample
- Delivers high yields of functional, high quality exosomes
- Can be used to isolate exosomes for a wide range of downstream applications, including
- Biomarker studies
- Exosomal miRNA profiling
- Exosomal proteomics
- Exosomal lipidomics/metabolomics
- Functional studies, such as in cell-to-cell signaling
- Basic biology, such as role in tumorigenesis
ExoQuick-TC is a proprietary polymer that gently precipitates exosomes. First, pre-clear your samples of cells and cellular debris, and then simply add the appropriate amount of ExoQuick-TC to your cleared biofluid, refrigerate, and centrifuge (see the product manual for protocol details). Your exosomes will be in the pellet, ready for resuspension in an appropriate solution.
Biofluid | Sample volume | ExoQuick-TC Volume |
---|---|---|
Tissue culture media, urine, cerebrospinal fluid (CSF), etc. | 5 mL | 1 mL |
In electron microscopy studies, exosomes isolated with ExoQuick-TC appear similar to exosomes isolated using ultracentrifugation1-2, and these exosomes are also active in numerous functional assays1-3.
Exosomes isolated with ExoQuick-TC can be used for all types of protein profiling and protein characterization studies, such as mass spectrometry, Western blotting, ELISA, and more. Higher protein yields are achieved by ExoQuick purification than by chromatography, DynaBeads, or ultracentrifugation.
Exosomes isolated with ExoQuick-TC also provide excellent samples for studying exosome-associated nucleic acids such as microRNAs, siRNAs, and even mRNA. Quantitative analytical techniques such as qPCR, microarray studies, and next-generation sequencing are all compatible with nucleic acids isolated from ExoQuick-TC-purified exosomes.
Backed by a growing number of publications, ExoQuick-TC is often the best option for researchers working with low sample volumes, such as clinical research samples or small animal models.
ExoQuick-TC exosome isolation methods are patented technologies4.
Choose the right ExoQuick for your application:
Application | Product | Catalog # |
---|---|---|
Purest EV isolation | ExoQuick ULTRA and ExoQuick-TC ULTRA | EQULTRA-20A-1 EQULTRA-20TC-1 |
General purpose EV isolation | ExoQuick and ExoQuick-TC | EXOQ20A-1 EXOTC50A-1 |
EV isolation for pre-clinical/in vivo studies | ExoQuick-CG | EXOCG50A-1 |
EV isolation that removes contaminating lipoprotein particles from plasma or serum | ExoQuick-LP | EXOLP5A-1 |
EV isolation that includes a de-fibrinating plasma step prior to isolation | ExoQuick Plasma Prep with Thrombin | EXOQ5TM-1 |
REFERENCES
- Chugh PE, et al. Systemically Circulating Viral and Tumor-Derived MicroRNAs in KSHV-Associated Malignancies. PLoS Pathog. 2013. 9(7): e1003484. PMCID: PMC3715412.
- Umezu T, et al. Leukemia cell to endothelial cell communication via exosomal miRNAs. Oncogene. 2013 May 30. 32(22):2747-55. PMID: 22797057.
- Sohel MM, et al. Exosomal and Non-Exosomal Transport of Extra-Cellular microRNAs in Follicular Fluid: Implications for Bovine Oocyte Developmental Competence. PLoS One. 2013 Nov 4. 8(11):e78505. PMCID: PMC3817212.
- Antes T, et al. Methods for Microvesicle Isolation and Selective Removal. Patent No.: US 9,005,888 B2.
SystemBiosciences,简称SBI,美国加利福尼亚湾区新成立的生技公司,致力于独特,创新生物技术之开发,以研发利于基因及蛋白质功能鉴定,研究之崭新方法和工具为宗旨。
美国SBI代理SystemBiosciences,简称SBI,美国加州湾区新成立的生技公司,致力于独特、创新生物技术之开发,以研发利于基因及蛋白质功能鉴定、研究之崭新方法和工具为宗旨。现阶段研发重心为RNA干扰(RNAi)研究之相关工具。
现阶段研发重心为RNA干扰(RNAi)的研究之相关工具。系统Biosciences公司(SBI)致力于开发独特,革新的技术,为客户研究蛋白组学和基因组学功能提供研究工具.SBI是专业的慢病毒产品公司,提供基于慢病毒的所有相关产品,质粒,试剂盒及相关配套试剂和慢病毒扩展产品,如IPS细胞多功能性诱导试剂盒和RNAi筛选文库。System Biosciences继续创造新的独特产品以及改善我们完善的产品线。我们对提供领先技术的承诺与我们所有研究试剂和研究项目服务的高质量制造和质量控制相匹配。 2009年要寻找的东西:以下是即将推出的新产品。新型miRZips™:基于慢病毒载体的新型技术可永久敲低MicroRNA。双标记shRNA表达载体:SBI将发布新的功能强大的shRNA表达慢病毒载体pGreenPuro™,以便为稳定的RNAi实验选择稳定转导的细胞的GFP和Puro标记。甾醇反应pGreenFire™慢病毒报告子:基于慢病毒载体的转录报告子,用于监测与固醇感应转录因子相关的转录网络活性-心血管疾病途径的关键。诱导型表达慢载体:新的构建体将允许CDNA,shRNA和microRNA的“按需”表达。2007–2008年的新产品新的miR-SNaRE:MicroRNA小型非编码RNA富集系统,该系统使用带有表位标签的microRNA加工因子来提取蛋白质及其相关RNA。识别驱动RISC复合体的信使RNA。新的GeneNet™聚焦的shRNA库:这些聚焦的shRNA库编码一组针对所有与人类激酶,磷酸酶或细胞凋亡相关基因有关的特定功能或类别基因设计的shRNA集合。这些文库可进行有针对性的高通量RNAi筛选。新的miRNomeMicroRNA分析仪:qPCR阵列在预先格式化的板中包括microRNA分析,可用于人类的完全互补或小鼠单个microRNA的完全互补,每块板上带有三个内源参考RNA对照。所有基于SangermiRBasemicroRNA数据库的microRNA分析均已注册。新的Lenti-miR™MicroRNA前体克隆:在基于HIV的慢病毒载体中可获得更多的microRNA前体集合。超过580个单独的microRNA前体克隆可用阵列形式或合并的慢病毒形式用于HT筛选。新的基于慢病毒的干细胞报道者:SBI越来越多的慢病毒载体已被开发为将基因构建体在体内外几乎传递给任何细胞类型的最有效方法。SBI已将我们的慢病毒构建体系列扩展为干细胞报道分子。使用连接到GFP报告基因的细胞和途径特异性启动子,轻松创建转基因细胞系以监测细胞分化。QuantiMir™RT试剂盒:这项流行的新技术可通过一次cDNA合成同时进行实时qPCR定量分析数百种microRNA。设计您自己的microRNA测定法以进行创新性实验。癌症microRNAqPCR分析小组(OncoMir系列):预格式化的microRNA分析小组,用于评估95种已知与癌症有关的microRNA。干细胞microRNA分析小组:介绍了95种参与干细胞分化的microRNA,可同时监测干细胞的自我维持,造血途径和神经分化。SBI完善的产品线FullSpectrum™完整信使RNA扩增试剂盒:利用针对mRNA最常见基序的mRNA特异性引物提供完整的mRNA转录物(5"和3"末端)的无偏见,完整代表。GeneNet™siRNA库:全基因组,即用型,预包装的慢病毒库为筛选与生物学反应相关的基因功能提供了令人兴奋的机会。干扰素反应检测试剂盒:区分真正的RNA干扰和压力相关的细胞反应。PathNet™转录报告基因慢病毒载体:一种独特的方法,可创建各种稳定的报告基因细胞系,用于信号通路的研究。我们感谢您过去的支持,并期待为您提供最佳的新试剂,技术和服务,以加速您成功的研究目标。
ebiomall.com






>
>
>
>
>
>
>
>
>
>
>
>


View Products
View Products
View Products